Imagify™ Bibliography
Papers and Abstracts
Senior, Expert Rev Cardiovasc Ther. 2007; 5: 413-421. Imagify™ (perflubutane polymer microspheres) injectable suspension for the assessment of coronary artery disease
Straub JA et al, Journal of Controlled Release. 2005; 108: 21-32. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography
Weissman NJ et al, JASE. 2004; 17 (5): Abstract P 2-11. Chronotropic Response After Dipyridamole Correlates with Increased AI-700 Echo and Nuclear Perfusion Sensitivity in Patients Screened for Coronary Disease
Grayburn PA et al, JASE. 2004; 17(5): Abstract P 1-23. Comparison of AI-700 Echo and Nuclear Perfusion Imaging to Coronary Angiography in Patients with Suspected Coronary Disease
Weissman NJ et al, JASE. 2001; 14(5): Absract P 3-4. Comparison of Myocardial Contrast Echo to 99mtc MIBI SPECT in Patients with Myocardial Perfusion Defects: A Phase 2 Study of AI-700™
Picard M et al, JASE. 2001 ; 14(5): Abstract P 3-2.The Effects of AI-700 Echo-Contrast perfusion And/Or Wall Motion Imaging On Detection of perfusion Defects In Patients With CAD
Walovitch RC, et al. JASE, 13(5) Abstract 457. Initial Safety and Myocardial Perfusion Imaging Results with AI-700T: A New Ultrasound Contrast Agent
Yao J, et al. JASE 2002; 15(7): 686-694. Evaluation of a new ultrasound contrast agent (AI 700) using two-dimensional and three-dimensional imaging during acute ischemia